Cargando…

Wnt and Src signals converge on YAP‐TEAD to drive intestinal regeneration

Wnt signalling induces a gradient of stem/progenitor cell proliferation along the crypt‐villus axis of the intestine, which becomes expanded during intestinal regeneration or tumour formation. The YAP transcriptional co‐activator is known to be required for intestinal regeneration, but its mode of r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guillermin, Oriane, Angelis, Nikolaos, Sidor, Clara M, Ridgway, Rachel, Baulies, Anna, Kucharska, Anna, Antas, Pedro, Rose, Melissa R, Cordero, Julia, Sansom, Owen, Li, Vivian S W, Thompson, Barry J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246259/ https://www.ncbi.nlm.nih.gov/pubmed/33950519 http://dx.doi.org/10.15252/embj.2020105770

Ejemplares similares

Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015)

Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability
por: Sidor, Clara, et al.
Publicado: (2019)

c-Src drives intestinal regeneration and transformation
por: Cordero, Julia B, et al.
Publicado: (2014)

Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression
por: Ning, Boting, et al.
Publicado: (2023)

Analysis in silico of the functional interaction between WNT5A and YAP/TEAD signaling in cancer
por: Astudillo, Pablo
Publicado: (2021)

Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018)

NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor
por: Novellasdemunt, Laura, et al.
Publicado: (2019)

Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors
por: Nouri, Kazem, et al.
Publicado: (2019)

FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling
por: Knyazeva, Anastasia, et al.
Publicado: (2020)

Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface
por: Gibault, Floriane, et al.
Publicado: (2018)

Multifaceted function of YAP/TEAD on chromatin:prospects of ‘A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer’
por: Chen, Lizhen, et al.
Publicado: (2019)

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
por: Kaan, Hung Yi Kristal, et al.
Publicado: (2017)

A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020)

Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge
por: Piersma, Bram, et al.
Publicado: (2015)

TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors
por: Cebola, Inês, et al.
Publicado: (2015)

Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive Müller Cells
por: Hamon, Annaïg, et al.
Publicado: (2017)

Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020)

Study of the TEAD‐binding domain of the YAP protein from animal species
por: Mesrouze, Yannick, et al.
Publicado: (2020)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019)

TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
por: Elster, Dana, et al.
Publicado: (2018)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD
por: Mesrouze, Yannick, et al.
Publicado: (2017)

Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells
por: Sun, Yang, et al.
Publicado: (2022)

YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
por: Stein, Claudia, et al.
Publicado: (2015)

YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells
por: Xia, Yan, et al.
Publicado: (2014)

Homeobox A4 suppresses vascular remodeling by repressing YAP/TEAD transcriptional activity
por: Kimura, Masahiro, et al.
Publicado: (2020)

YAP‐TEAD up‐regulates IRS2 expression to induce and deteriorate oesophageal cancer
por: Xu, Xiangming, et al.
Publicado: (2021)

Simplifying cancer: binary pan-cancer superclasses stratified by opposite YAP/TEAD effects
por: Pearson, Joel D., et al.
Publicado: (2021)

ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation
por: Esposito, Davide, et al.
Publicado: (2022)

The Telluride YAP/TAZ and TEAD Workshop: A Small Meeting with a Big Impact
por: Weinberg, Guy L., et al.
Publicado: (2023)

YAP/TEAD-induced PRIM1 contributes to the progression and poor prognosis of gastric carcinoma
por: Guo, Zijun, et al.
Publicado: (2023)

A covalent inhibitor of the YAP–TEAD transcriptional complex identified by high-throughput screening
por: Nutsch, Kayla, et al.
Publicado: (2023)

USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination
por: Novellasdemunt, Laura, et al.
Publicado: (2017)

Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
por: Feng, Juntao, et al.
Publicado: (2016)

NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma
por: Luo, Xiaoling, et al.
Publicado: (2017)

Author Correction: TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
por: Elster, Dana, et al.
Publicado: (2018)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
por: Qi, Yangfan, et al.
Publicado: (2016)

YAP/TEAD1 Complex Is a Default Repressor of Cardiac Toll-Like Receptor Genes
por: Gao, Yunan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kcip80juk96mkqih9n199rbsu5